Bronchiectasis Drugs Market to record USD 276.16 Mn growth; High growth expected in antibiotics segment - Technavio

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- The "Bronchiectasis Drugs Market by Product and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The report expects the market size to grow by USD 276.16 million, accelerating at a CAGR of 9.31% between 2021 and 2026. The report provides a detailed analysis of the impact of the COVID-19 pandemic on the bronchiectasis drugs market in optimistic, probable, and pessimistic forecast scenarios. The report also offers an up-to-date analysis of the current global market scenario and the overall market environment. Read A Free PDF Sample Report

Bronchiectasis Drugs Market 2022-2026: Scope

To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. Backed with competitive intelligence and benchmarking, our research reports on the bronchiectasis drugs market are designed to provide entry support, customer profile, & M&As as well as go-to-market strategy support.

The report also covers the following areas:

• Bronchiectasis Drugs Market Size
• Bronchiectasis Drugs Market Trends
• Bronchiectasis Drugs Market Industry Analysis

Bronchiectasis Drugs Market 2022-2026: Segmentation

• Product 
• Antibiotics
• Expectorants
• Others

The antibiotics segment will have the largest share of the market. The growth of the segment is driven by factors such as the low cost of drugs and their availability, affordability, and accessibility. Even though all the pathogens associated with the respiratory system resist various antibiotics, a single antibiotic cannot inhibit all the pathogens in and around the respiratory tract. Hence, various antibiotics are used in combination to achieve the desired clinical outcome. This increases the volume consumption of antibiotics, which drives the growth of the segment.

• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

47% of the market growth will come from North America during the forecast period. The market in North America is primarily driven by the sales of various off-label drug therapies approved for other chronic respiratory conditions and the increasing prevalence of chronic respiratory diseases and bronchiectasis. In addition, the use of antibiotics in combination with alternative treatment options, due to the absence of approved therapies, is expected to drive the bronchiectasis drugs market in the region during the forecast period.

Discover key revenue-generating segments and regional growth opportunities and make
informed business decisions. Buy Now!

Bronchiectasis Drugs Market 2022-2026: Vendor Analysis

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AbbVie Inc., Akorn Operating Co. LLC, Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd, Neopharma Corp., Pfizer Inc., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Virtus Pharmaceuticals LLC, and Wockhardt Ltd. are some of the major market participants.

The Increasing cases of associated risk factors will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments while maintaining their positions in the slow-growing segments.

Technavio's library includes over 17,000+ reports covering more than 2,000 emerging
technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to
our Technavio Insights

Bronchiectasis Drugs Market 2022-2026: Key Highlights

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist bronchiectasis drugs market growth during the next five years
• Estimation of the bronchiectasis drugs market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the bronchiectasis drugs market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of bronchiectasis drugs market vendors

Related Reports:

• The bronchitis treatment market share is expected to increase by USD 1.12 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.76%. The increasing prevalence of smoking is notably driving the bronchitis treatment market growth, although factors such as the high cost of healthcare may impede the market growth.
• The bronchoscopes market share is expected to increase by USD 882.88 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.82%. The technological advances in bronchoscopy is notably driving the bronchoscopes market growth, although factors such as the high cost of bronchoscopy may impede the market growth.

Table of contents:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments 
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

• 5.2 Comparison by Product 
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product

• 5.3 Antibiotics - Market size and forecast 2021-2026
• Exhibit 28: Chart on Antibiotics - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Antibiotics - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Antibiotics - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Antibiotics - Year-over-year growth 2021-2026 (%)

• 5.4 Expectorants - Market size and forecast 2021-2026
• Exhibit 32: Chart on Expectorants - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Expectorants - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Expectorants - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Expectorants - Year-over-year growth 2021-2026 (%)

• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Product 
• Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 88: Matrix on vendor position and classification

• 10.3 AbbVie Inc. 
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings

• 10.4 Akorn Operating Co. LLC 
• Exhibit 92: Akorn Operating Co. LLC - Overview
• Exhibit 93: Akorn Operating Co. LLC - Product / Service
• Exhibit 94: Akorn Operating Co. LLC - Key offerings

• 10.5 Amneal Pharmaceuticals Inc. 
• Exhibit 95: Amneal Pharmaceuticals Inc. - Overview
• Exhibit 96: Amneal Pharmaceuticals Inc. - Business segments
• Exhibit 97: Amneal Pharmaceuticals Inc. - Key news
• Exhibit 98: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibit 99: Amneal Pharmaceuticals Inc. - Segment focus

• 10.6 Aurobindo Pharma Ltd. 
• Exhibit 100: Aurobindo Pharma Ltd. - Overview
• Exhibit 101: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 102: Aurobindo Pharma Ltd. - Key offerings

• 10.7 Bayer AG 
• Exhibit 103: Bayer AG - Overview
• Exhibit 104: Bayer AG - Business segments
• Exhibit 105: Bayer AG - Key offerings
• Exhibit 106: Bayer AG - Segment focus

• 10.8 Endo International Plc 
• Exhibit 107: Endo International Plc - Overview
• Exhibit 108: Endo International Plc - Business segments
• Exhibit 109: Endo International Plc - Key news
• Exhibit 110: Endo International Plc - Key offerings
• Exhibit 111: Endo International Plc - Segment focus

• 10.9 GlaxoSmithKline Plc 
• Exhibit 112: GlaxoSmithKline Plc - Overview
• Exhibit 113: GlaxoSmithKline Plc - Business segments
• Exhibit 114: GlaxoSmithKline Plc - Key offerings
• Exhibit 115: GlaxoSmithKline Plc - Segment focus

• 10.10 Neopharma Corp. 
• Exhibit 116: Neopharma Corp. - Overview
• Exhibit 117: Neopharma Corp. - Product / Service
• Exhibit 118: Neopharma Corp. - Key news
• Exhibit 119: Neopharma Corp. - Key offerings

• 10.11 Pfizer Inc. 
• Exhibit 120: Pfizer Inc. - Overview
• Exhibit 121: Pfizer Inc. - Product / Service
• Exhibit 122: Pfizer Inc. - Key news
• Exhibit 123: Pfizer Inc. - Key offerings

• 10.12 Reckitt Benckiser Group PLC 
• Exhibit 124: Reckitt Benckiser Group PLC - Overview
• Exhibit 125: Reckitt Benckiser Group PLC - Business segments
• Exhibit 126: Reckitt Benckiser Group PLC - Key offerings
• Exhibit 127: Reckitt Benckiser Group PLC - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 130: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources

• 11.5 List of abbreviations 
• Exhibit 134: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio